The derivation of human ES cells from in vitro fertilized embryos 1 is relevant for cell-based therapies, and while iPS cell technology 2,3 overcomes allogenicity issues, a high frequency of genetic and epigenetic abnormalities have been observed, including subchromosomal duplications and deletions detected as copy number variations (CNVs) 4, 5 , protein-coding mutations 6 and defects in DNA methylation and gene expression at regions subject to imprinting and X-chromosome inactivation [7] [8] [9] [10] . Although it is not yet understood whether these aberrant epigenetic marks reflect errors arising during reprogramming or incomplete reversion to pluripotency, they could impact the accuracy of in vitro disease modelling or, more importantly, the utility of iPS cells for regenerative medicine. With the availability of somatic cell nuclear transfer as an alternative approach to somatic cell reprogramming 11 , we explored the mechanisms underlying transcription factor-and SCNT-based reprogramming.
Genetically matched cell lines
In addition to four NT ES cell lines derived from fetal human dermal fibroblasts (HDFs), designated NT1-NT4 (ref. 11), we generated seven iPS cell lines from the same HDFs using retroviral vectors 12 (two lines, named iPS-R1 and iPS-R2) and Sendai-virus-based vectors 13 (five lines, named iPS-S1, iPS-S2, iPS-S3, iPS-S4 and iPS-S5). Two IVF ES cell lines (human ES Oregon (hESO)-7 and hESO-8) were derived following IVF of oocytes from the same egg donor used for SCNT 11 . All cell lines maintained typical morphology, expressed pluripotency markers, formed teratomas and retained diploid karyotypes with no detectable numerical or structural chromosomal abnormalities.
Short tandem repeat (STR) genotyping verified that all NT ES cell and iPS cell lines were genetically matched to each other and to HDFs.
The one exception to this was iPS-R1, which had a homozygous D3S1768 locus on chromosome 3 (Supplementary Table 1) , whereas all other lines were heterozygous at this locus.
SNP genotyping also confirmed that all NT ES cell and iPS cell lines were essentially identical to each other and to the HDFs in terms of their nuclear genomes (.99.96% similarity, Supplementary Table 2 ). Oocyte and sperm donors showed first-degree genetic relationships to IVF ES cells.
Using whole methylome and transcriptome sequencing, the mitochondrial DNA (mtDNA) in NT ES cells matched those of the IVF ES cells, whereas the iPS cell and HDF sequences differed from those of the IVF ES cells at 13 nucleotide positions (Extended Data Fig. 1a, b) . Consistent with previous measurements, we detected a small amount of HDF mtDNA carryover (1-4.9%) in some NT ES cells (Supplementary Table 3 ).
Subchromosomal aberrations
High-throughput SNP genotyping identified ten de novo CNVs in earlypassage iPS cells and three in NT ES cells (Extended Data Fig. 2a ). NT3 carried a one-copy deletion on chromosome 16, and NT4 had two duplications on chromosomes 3 and 6. Among the iPS cells, iPS-S1 harboured two duplications on chromosomes 1 and 5; iPS-S2 had three one-copy deletions on chromosomes 1, 4 and 17; iPS-S3 carried a single one-copy deletion on chromosome 10; iPS-R1 displayed two duplications on chromosomes 3 and 4, one large run of homozygosity (ROH) encompassing most of the short arm of chromosome 3 and one two-copy deletion within the ROH. This ROH was consistent with STR analysis (Supplementary Table 1 ). A single one-copy deletion on the X chromosome was identified in human hESO-7. All CNVs were validated using quantitative PCR (qPCR) analysis (Extended Data Table 1 ).
CNV analysis was extended to a second matched set, consisting of NT ES cell (Leigh-NT1) and iPS cell lines (Leigh-iPS1, Leigh-iPS2 and LeighiPS3) derived from a patient with Leigh syndrome 11 . G-banding did not reveal any numerical or chromosomal abnormalities and STR genotyping corroborated that all lines were from the Leigh patient (Leigh-fib, Supplementary Table 1) . Leigh-NT1 carried oocyte mtDNA while all Leigh iPS cells inherited patient mtDNA including the homoplasmic m.8993T.G mutation 14 (Extended Data Fig. 1c ). Nine de novo CNVs were identified in this data set, including multiple CNVs in Leigh-iPS1 and Leigh-iPS3 and one each in Leigh-iPS2 and Leigh-NT1 (Extended Data Fig. 2a and Extended Data Table 1 ).
In summary, iPS cells, NT ES cells and IVF ES cells carried an average of 1.8, 0.8 and 0.5 CNVs per line, respectively (Extended Data Fig. 2b) , with no statistically significant differences among cell types. InDel analysis using RNA sequencing (RNA-seq) also showed a trend towards fewer mutations in NT ES cells compared with iPS cells, but the differences among cell types were again not statistically significant (P . 0.05, Extended Data Fig. 2c, d ). Thus, it seems that the mutagenic and selective pressures for both reprogramming approaches are not statistically different, but this conclusion is limited by the small numbers of cell lines analysed.
Global DNA methylation
DNA methylation is an important epigenetic mechanism contributing to cell identity, and significant differences have been reported between iPS cells and IVF ES cells 7, 15 . Therefore, we examined genome-wide DNA methylation of our cell lines and compared them to publicly available samples using the Infinium HumanMethylation450 BeadChip. Unsupervised hierarchical clustering 16 and bootstrap resampling identified two welldefined clusters, one containing all iPS cell lines and one IVF ES cell line from a previous study (HUES64 (ref. 17) ), and another with all NT ES cell lines and four IVF ES cell lines (Fig. 1a, b) . Intra-group variability was assessed using the coefficient of variation for each stem cell type and was found to be similar to previously reported cell lines 17 (Fig. 1c) . Functional enrichment analysis of probes that were highly methylated in iPS cells and HDFs compared to IVF ES cells indicated association with sequence-specific DNA binding transcription factor activity (2.02-fold enrichment, FDR , 0.0001). No significant annotation terms were found for hypermethylated probes shared by NT ES cells and HDFs. However, probes that were hypomethylated in iPS cells, NT ES cells and HDFs were enriched for loci associated with the major histocompatibility complex (MHC) class II protein complex (72-fold enrichment, FDR , 0.001).
We conclude that methylation profiles of NT ES cells are more similar to IVF ES cells than to iPS cells. Both cell types carry residual HDF epigenetic memory, but iPS cells retain eightfold more of such sites. Interestingly, nearly 80% of DMPs in NT ES cells, but only 12% in iPS cells, could be related to somatic memory, suggesting that the majority of methylation abnormalities in iPS cells result from reprogramming errors.
DNA methylation at imprinted and XCI regions
Aberrant methylation at imprinted loci has been observed in iPS cells 7, 18, 19 . We interrogated previously identified imprinted regions 7, 20, 21 ( Fig. 2a ) considering CpGs with a b 5 0.2-0.8 on the DNA methylation microarray as partially methylated, .0.8 aberrantly hypermethylated, and ,0.2 hypomethylated. Our cell line variances within these imprinted regions were comparable to other independently generated cells 17 (our lines, coefficient of variation 5 0.27-0.36; coefficient of variation 17 5 0.28-0.4). Based on unsupervised hierarchical clustering within imprinted regions, NT ES cell lines grouped closely with IVF ES cells and displayed fewer aberrantly methylated probes compared to iPS cells (Fig. 2a, b) .
In terms of aberrant DNA methylation at imprinted regions, all NT ES cells displayed hypomethylation at GNAS (also known as GNAS complex locus); NT2 and NT3 were hypermethylated at probes located in the genomic region of GNASAS (also known as GNAS antisense RNA 1) and GNAS overlap; and NT4 was hypomethylated at H19 (also known as imprinted maternally expressed transcript (non-protein coding)) (Fig. 2a) , which corresponded with bi-allelic expression of this gene (Extended Data Table 2 ). All iPS cells and the hESO-7 cell line were hypermethylated at PEG3 (also known as paternally expressed 3) (Fig. 2a) , while only the iPS cells displayed hypermethylation at MEG3 (also known as maternally expressed 3 (non-protein coding)) (Fig. 2a) . These genes displayed reduced expression of corresponding transcripts ( Fig. 2c ; MEG3 adjusted P , 0.001, average fold change, 19.8; PEG3 adjusted P , 0.005, average fold change, 128.9). The DIRAS3 (also known as DIRAS family, GTP-binding RAS-like 3) locus was hypermethylated in all iPS cells, but a corresponding change in gene expression was not seen (Fig. 2a) . 
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X-chromosome inactivation (XCI) can be detected by allele-specific expression and coating of the X chromosome by the long noncoding RNAs XIST (also known as X inactive specific transcript (non-protein coding)) and XACT 22, 23 . Based on RNA-seq, all female cells in our dataset expressed similar levels of XIST, but only pluripotent cells expressed XACT (Extended Data Fig. 3a, b) . hESO-8 (male) was unmethylated at previously annotated XCI loci 7 , whereas all female lines were predominantly partially methylated (b 5 0.2-0.8; Fig. 3a) . NT ES cells and IVF ES cells demonstrated higher DNA methylation levels at XCI loci compared to HDFs. However, methylation levels in iPS cells were significantly higher than in NT ES cells and female hESO-7 ( Fig. 3b , P,0.001), with substantial variation among lines. With aberrant methylation defined as b , 0.2 or . 0.8, NT ES cells and hESO-7 had fourfold fewer aberrations than iPS cells ( Fig. 3c , P , 0.001). POU3F4 (also known as POU class 3 homeobox 4), SLITRK2 (also known as SLIT and NTRK-like family, member 2) and SLITRK4 (also known as SLIT and NTRK-like family, member 4) hypermethylation in iPS-R2 correlated with lower gene expression while hypomethylation of DACH2 (also known as Dachshund homologue 2), RPS6KA6 (also known as ribosomal S6 kinase 4) and CHM (also known as choroideremia rab escort protein 1) in iPS-R1 and TMEM187 (also known as transmembrane protein 187) in iPS-S2 correlated with increased gene expression (Fig. 3a and Extended Data Fig. 4a, b) .
Autosomal non-imprinted loci
Differential DNA methylation analysis of autosomal non-imprinted sites revealed 1,621 DMPs between our groups (Kruskal-Wallis test, P , 0.01, Db . 0.5). We grouped these probes into six major clusters using an unsupervised self-organizing map algorithm 24 (Extended Data Fig. 5 ). All six clusters were analysed for cis-regulatory functional enrichments using GREAT 25 , but only cluster 3 showed significant enrichments for categories associated with morphogenesis and neural development (Supplementary Table 4 ). iPS cells displayed higher DNA methylation levels compared to NT ES cells and IVF ES cells for most clusters, with the exception of cluster 4, in which the highest DNA methylation was seen in the IVF ES cells. NT ES cells displayed intermediate DNA methylation, but overall were closer to IVF ES cells. We examined several different probe subsets, and noted higher methylation levels in iPS cells compared to IVF ES cells, as reported previously 26, 27 (Extended Data Fig. 6a-o) .
Whole-genome bisulphite sequencing
To gain a more detailed picture of the underlying methylation differences in our cells, we generated high-coverage base-resolution methylomes (143 to 253) using MethylC-seq 8 . We also assessed the methylomes of three additional IVF ES cells (H1, H9 and HUES6) [28] [29] [30] . Hierarchical clustering at CG differentially methylated regions (DMRs) demonstrated that the methylation landscape of NT ES cells more closely matched IVF ES cells compared to iPS cells (Fig. 4a) . By comparing the methylomes and filtering regions that were obscure or highly variable in IVF ES cells, 678 CG DMRs were identified (Supplementary Table 5 ) that were present in at least one NT ES cell or iPS cell line but not in IVF ES cells (FDR 5 0.01). Most of these CG DMRs were identified within iPS cells (619), whereas NT ES cells contained threefold fewer (212) and 153 CG DMRs were shared (Fig. 4b) . Using a similar approach, we calculated that five previously profiled iPS cells 8 carried a total of 792 CG DMRs, suggesting that both iPS cell groups are comparable. Most of the CG DMRs were localized within CG islands and gene bodies (Fig. 4c) 
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GNASAS/GNAS (n = 6) cell line had fewer aberrant regions than any of the iPS cell lines ( Fig. 4d , P 5 0.0147, Mann-Whitney test). CG DMRs were then assigned into three groups: memory DMRs (mDMRs; shared with HDF), NT-specific DMRs (ntDMRs) and iPS-cell-specific DMRs (iDMRs). On average, 38% of total CG DMRs in the NT ES cell lines and 22% of DMRs in iPS cells were mDMRs (Fig. 4d) . Inspection of the recurrent CG DMRs (hotspot DMRs 8 ) in every iPS cell or NT ES cell line revealed that NT ES cell lines had 50 hotspot DMRs, or twofold fewer than iPS cells (104) (Fig. 4e) . Interestingly, 48 of 50 hotspot DMRs in NT ES cells were also shared with iPS cells (P , 0.001, Hypergeometric test). Of the hotspot DMRs shared among all 8 cell lines 63% (30 out of 48) were mDMRs, suggesting regions resistant to reprogramming by either approach. Only 2 (4%) hotspot DMRs were unique to NT ES cells compared to 56 (54%) iPS-cell-specific hotspots (Fig. 4e) .
Non-CG methylation in NT ES cells
We previously identified pervasive and exclusive non-CG methylation in pluripotent cells 31 . We also reported that iPS cells carry frequent aberrant non-CG methylations 8 . We identified regions showing megabasescale non-CG methylation differences (non-CG mega DMRs) in NT ES cells and iPS cells when compared to IVF ES cells. Five IVF ES cell lines, two from this study and the three described previously, served as our control methylation landscape [28] [29] [30] . Autosomal non-CG mega DMRs (150) were identified when the methylomes of 13 iPS cell lines and NT ES cell lines were compared to controls (Extended Data Fig. 7a and Supplementary Table 6 ). Non-CG mega DMRs linked to the sex chromosomes were excluded due to the mixed gender of controls. A total of 150 autosomal non-CG mega DMRs covered 123 megabases (Mb) of genome and included all regions reported previously 8 (99% of bases); of these, 77 non-CG mega DMRs were identified from the iPS and NT cells, 70 of which occurring exclusively in iPS cells (Fig. 5a ). These DMRs were distributed on every autosomal chromosome except chromosome 13 ( Fig. 5b ). Only 7 non-CG mega DMRs (tenfold less) were present in NT ES cells. Consistent with our previous findings 8 , non-CG mega DMRs were significantly closer to centromeric and telomeric regions compared with shuffled non-CG mega DMRs ( Fig. 5b , P , 0.001). We also observed several different patterns of aberrant non-CG methylation, including hypomethylation in iPS cells only, or in both NT ES cells and iPS cells, and hypermethylation in iPS cells only (Extended Data Fig. 7b , c, d). However, the vast majority of non-CG mega DMRs (92.5% of total bases) were hypomethylated in iPS cells and/or NT ES cells compared with IVF ES cells (Fig. 5c ).
We asked whether methylomes from our four iPS cells were similar to other iPS cells 8 . The former contained a total of 75 DMRs, while the latter carried 121, indicating that despite different somatic cell origin and culture conditions, iPS cells carried similar levels of aberrant non-CG methylation. In contrast, NT ES cells showed the least amount of aberrant non-CG methylation ( Fig. 5c, d ; P , 0.005). Hierarchical clustering for all non-CG mega DMRs also supported the conclusion that the NT ES cells are more similar to IVF ES cells (Extended Data Fig. 7a ).
To understand the functional impact of non-CG mega DMRs, we focused on transcriptional activity within those regions. On average, 2 genes in NT ES cells and 30 in iPS cells were located within non-CG mega DMRs, implying that fewer genes in NT ES cells are affected (Extended Data Fig. 8a, b ; P 5 0.0147). Gene ontology analysis 32 for genes in hypomethylated non-CG DMRs revealed that these genes were related to olfactory transduction, epidermal cell differentiation, cytoskeleton, immunoglobulin and homeobox proteins (FDR # 0.001; Supplementary Table 7) . Gene expression in the iPS cells for 2 genes in the hypermethylated non-CG mega DMRs was upregulated (Extended Data Fig. 8c , P , 0.05), whereas expression of 24 genes in the iPS cells and 6 genes in the NT ES cells in the hypomethylated non-CG mega DMRs were down regulated (Extended Data Fig. 8d, e ; P , 0.001). These observations indicate that NT ES cells were more faithfully reprogrammed to a state closely matching IVF ES cells compared to iPS cells. Particularly, NT4 had the least aberrant methylation in both CG and non-CG contexts.
Global gene expression
Lastly, we examined global gene expression patterns from strand-specific RNA-seq. Consistent with DNA methylation, intra-group variability was similar among cell types (coefficients of variation: NT ES cells 5 1.41, IVF ES cells 5 1.45, iPS cells 5 1.44) and unsupervised hierarchical clustering positioned NT ES cells closely with IVF ES cells (Fig. 6a) . Differential expression analysis (FDR , 0.05) yielded 1,220-transcripts, grouped into 10 clusters. The majority (65%) of these genes were either significantly upregulated or downregulated in iPS cells compared to NT ES cells and IVF ES cells. Clusters 2 and 3 showed higher gene expression in NT ES cells and IVF ES cells compared to iPS cells; when subjected to functional enrichment analysis, these clusters were associated with p38 MAPK signalling pathway genes (FDR 5 0.02; n 5 51) and Krueppel-associated box genes (FDR 5 0.001; n 5 91). Cluster 10 contained transcripts that were upregulated in Based on differential expression analysis, we searched for genes displaying transcriptional memory in both iPS cells and NT ES cells. Three separate t-tests between HDFs and IVF ES cells, NT ES cells and IVF ES cells and iPS cells and IVF ES cells were conducted at a FDR cut-off of 0.05. We found 24 genes that were expressed at significantly lower levels in the NT ES cells and HDFs compared to IVF ES cells, probably indicating incompletely reactivated genes, and 12 genes that were expressed at significantly higher levels representing incompletely silenced genes (Fig. 6b) . In contrast, 171 genes were incompletely reactivated and 32 were incompletely silenced in iPS cells.
We found that incompletely reactivated genes in iPS cells also retained significantly higher promoter methylation (P , 2.2 3 10
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, MannWhitney test), possibly indicating incomplete demethylation during reprogramming (Fig. 6c) . Overall, the gene expression and DNA methylation results were consistent, both suggesting that NT ES cells are more similar to IVF ES cells than to iPS cells.
Conclusions
Here, we showed that transcription-factor-based reprogramming is associated with incomplete epigenetic reprogramming. In contrast, the same somatic cells reprogrammed by SCNT displayed epigenetic and transcriptional signatures remarkably similar to those of IVF ES cell controls.
Both NT ES cells and iPS cells contained similar levels of de novo CNVs, with some lines (iPS-R2, iPS-S4, iPS-S5 and NT1 and NT2) displaying no detectable alterations. This observation indicates that screening of multiple cell lines may allow recovery of genetically normal lines. However, CNV analysis does not completely exclude the presence of point mutations, small indels, or translocations. Indeed, exome sequencing has demonstrated that iPS cells carry, on average, six non-synonymous point mutations per line 33 . Using genome-wide microarray-based DNA methylation as an indicator of reprogramming, we demonstrated that NT ES cells undergo more complete reprogramming than iPS cells. We also confirmed the persistence of somatic patterns of CpG methylation in human iPS cells, consistent with a mouse study 34 . Although NT ES cells also carried evidence of epigenetic memory, iPS cells contained eightfold more CpG sites that retained the DNA methylation pattern of parental HDFs. Whole-genome bisulphite sequencing was consistent with the DNA methylation microarray analysis, showing that iPS cells carried threefold more aberrant CG and tenfold more aberrant non-CG methylation compared to NT ES cells, indicating that SCNT reprogramming is capable of resetting the DNA methylation and corresponding gene expression program more faithfully than iPS cell reprogramming. An explanation for this more effective reprogramming by SCNT is that the ooplasm provides 'physiologic' levels of reprogramming factors that are upstream of pluripotency. It has been suggested that oocyte factors rapidly demethylate the somatic genome, whereas this process occurs passively during factor-based reprogramming 34 . Clearly, elucidation of oocyte-based reprogramming mechanisms will support the development of improved reprogramming protocols.
In summary, although IVF ES cells most closely resemble cells residing in embryos, they are allogeneic. Human iPS cells might remain the most facile cell type for many in vitro applications, but show extensive epigenetic and transcriptomic aberrations compared to NT ES cells and IVF ES cells. NT ES cells combine significant advantages of both types; epigenetic stability of IVF ES cells and the histocompatible nature of iPS cells. Further studies on additional NT ES cell lines, especially lines derived from aged patients, and their differentiation potential are now warranted.
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number of genes differentially expressed between the HDFs and the IVF ES cells (large circle), the iPS cells and the IVF ES cells (medium circle) and the NT ES cells and IVF ES cells (small circle; t-test FDR ,0.05). Overlapping regions represent the number of genes differentially expressed in both the
HDFs and either the NT ES cells or iPS cells. c, Notched box plots represent the b-value of all probes in the promoter regions (22,000 bp to 500 bp) of the genes that were expressed at significantly lower levels (t-test FDR , 0.05) in both the HDFs and the iPS cells (exhibiting transcriptional memory) when compared to the IVF ES cells. The box represents the interquartile range (25th to 75th percentile), and the line within the box marks, the median. The notch in the box represents the 95% confidence interval around the median. The whiskers above and below the box contain 99.3% of the data and the number of CpGs interrogated is shown on the y axis. . Sendai-virus-based reprogramming was carried out according to the manufacturer's protocol (CytoTune-iPS Reprogramming Kit, Life Technologies). Colonies with typical ES cell morphology were isolated and manually propagated similar to NT ES cell and IVF ES cell protocols 11 . All cell lines were propagated in Knockout DMEM medium (Invitrogen) supplemented with 20% of knockout serum replacement (KSR), 0.1 mM nonessential amino acids, 1 mM l-glutamine, 0.1 mM b-mercaptoethanol, 13 penicillinstreptomycin and 4 ng ml 21 basic fibroblast growth factor. All cell-line derivation, culture and DNA and RNA isolations were conducted in the Mitalipov laboratory. DNA methylation microarray analysis and statistics. DNA was purified from early passage cells (8-10) (QIAGEN Gentra Puregene Cell Kit), quantified (Qubit dsDNA BR Assay Kits, Life Technologies) and bisulphite-converted (EZDNA Methylation Kit, Zymo Research) according to the manufacturer's protocol. Bisulphiteconverted DNA was hybridized to the Infinium HumanMethylation 450K beadchip (Illumina) and scanned on a HiScan (Illumina). All samples passed GenomeStudio (Illumina) quality-control steps based on built-in control probes. Data obtained from our eleven samples were combined with three IVF ES cell lines and three iPS cell lines (HUES64, hiPS-27b, hiPS-17b, hiPS-20b, HUES13 and HUES1) 17 for hierarchical clustering and principle component analysis. We performed pre-processing and normalization using the statistical programming language R (http://www. r-project.org/) (v.3.0.1) and the R package minfi (v.1.6.0). In brief, intensity data files (.idat) were control-normalized and probes with detection P . 0.01 in at least one sample were discarded. The samples were then normalized using the SWAN normalization option in the minfi package and M values were exported. The R script, ComBat 35 was used to eliminate batch effects between our samples and the six additional samples. Global differential methylation probe analysis was done on our eleven samples using the dmpFinder function in minfi. Probes were considered differentially methylated if Q ,0.01. For autosomal non-imprinted loci, the probes were annotated 36 and probes with a documented SNP at the target CpG, probes that contained two or more SNPs, non-CpG probes, sex chromosome probes, and probes that mapped to multiple locations were removed. Hierarchical clustering was performed with the R package pvclust, with Euclidian distance and complete linkage. The somatic HDF sample was then removed and the remaining probes were filtered in Cluster 3.0 software 16 using a standard deviation filter of one. A Kruskal-Wallis test was then applied in R, and Q values were estimated using the R package Q value. Because b values are easier to interpret biologically, in the figures and results, we converted M values back to b values using the equation, b 5 2 M /2 M 1 1. To filter further the number of probes before clustering with an unsupervised self-organizing map algorithm 24 , the four NT ES cells samples, the two IVF ES cells samples and the four iPS cell samples were averaged and then only probes with a maximum -minimum value greater than 0.5 were clustered. The HDF sample was then added back for visualization purposes. Principle component analysis (PCA) plots were made using Qlucore Omics Explorer 2.3, each variable was standardized by subtraction of its mean value and division by its standard deviation across all samples, and heat maps were produced using Java TreeView (v.1.1.5r2) 21 and AutoSOME (v.2.1) 24 . All enrichment analysis was performed using GREAT (v.2.0.2) 25 with default settings. X chromosome inactivated and imprinted probes were obtained from ref. 7 and were analysed separately. Xchromosome-inactivated probes were filtered using a 0.25 variance filter after removing the male hESO-8 and HDF samples. Allelic expression was determined using the heterozygous SNPs on the Illumina Omni5 genotyping array found within the imprinted genes. To use a SNP, at least two RNA-seq reads needed to cover the SNP and at least five total RNA-seq reads (when adding all the SNPs within the gene) were required. For biallelic expression, we required at least one SNP to have over 20% of its overlapping RNA-seq reads expressing the alternative allele. RNA-seq library construction. RNA was isolated (passage 8-10) (TRIzol Reagent, Life Technologies), quantified (Qubit RNA Assay Kit, Life Technologies) and quality controlled (RNA6000 Nano Kit and BioAnalyzer 2100, Agilent). RNA (500 ng) from each sample was used as input for the Illumina TruSeq Stranded messenger RNA LT Sample Prep Kit (Illumina) and sequencing libraries were created according to the manufacturer's protocol. Briefly, poly-A containing mRNA molecules were purified using poly-T oligo-attached magnetic beads. Following purification, the mRNA was fragmented and copied into first strand complementary DNA using random primers and reverse transcriptase. Second strand cDNA synthesis was then done using DNA polymerase I and RNase H. The cDNA was ligated to adapters and enriched with PCR to create the final cDNA library. The library was pooled and sequenced on a HiSeq 2000 (Illumina) instrument per the manufacturer's instructions. Sequencing was performed up to 2 3 101 cycles. RNA-seq data processing. The RNA-seq reads were trimmed and mapped to the hg19 reference using STAR (v.2.3.0.1). On average, approximately 23 million reads were generated per sample, and 76% of these reads were uniquely mapped. Expression levels for each gene were quantified using the python script rpkmforgenes and annotated using RefSeq (archive-2012-03-09-03-24-410). Genes without at least one sample with at least ten reads were removed from the analysis. The data was then normalized using the R (v.3.0.1) package DESeq (v.1.12.0) and then batch corrected using the R script ComBat 35 . Differential expression analysis was carried out using ANOVA in Qlucore Omics Explorer 2.3. Transcripts with a Q value of less than 0.05 were considered differentially expressed. Differentially expressed genes were then clustered using the CLICK algorithm in Expander (v.6.06) with an expected mean homogeneity of 0.75. PCA and heatmaps were constructed using Qlucore Omics Explorer 2.3. Each variable was standardized by subtraction of its mean value and division by its standard deviation across all samples. All enrichment analysis was performed using GREAT (v.2.0.2) 25 with default settings. InDel analysis by RNA-seq. InDels were called for each sample by first mapping the RNA-seq reads using STAR (v.2.3.0.1) with stringent parameters (--scoreDelOpen 21 --scoreDelBase 21 --scoreInsOpen 21--scoreInsBase 21 --scoreGap 22 --scoreGapNoncan 2100 --alignIntronMax 100000 --seedSearchStartLmax 25 --outFilterMatchNmin 95) designed to limit the number of false positive InDels. Additionally, the RNA-seq reads were also trimmed using FASTX (v.0.0.13) and Trim Galore (v.0.2.2) and then mapped to the hg 19 reference genome using Tophat (v.2.0.6). The reads were then sorted, merged, deduplicated and mpileup files were created using Samtools (v.0.1.17). The mpileup files were then run through VarScan (v.2.3.6) with a P-value filter of 0.01 to call InDels. An InDel was considered only if it met the following criteria: it was not called in the parental HDF lines; it was called using both mapping programs; and it was called in both replicate samples. Five percent of InDels passing the above filtering steps were then verified using the IGV genome browser (v.2.3). Mitochondrial DNA SNP analysis by RNA-seq. Mapped and deduplicated .bam files were filtered for reads that mapped to human mtDNA using BamTools (v.1.0). These reads were then viewed in Integrated Genomics Viewer (v.2.3) and counts were recorded for differences between hg19 and any of our eleven samples. SNP genotyping and copy-number-variation assessment. SNP genotyping was performed on the Illumina Omni5, which interrogates 4.3 million SNPs across the human genome. All DNA was isolated (QIAGEN Gentra Puregene Cell Kit) except the sperm sample (PicoPure DNA Extraction Kit, Life Technologies), and quantified (Qubit dsDNA BR Assay Kits, Life Technologies) according to the manufacturer's protocol. Input genomic DNA (500 ng) was processed according to the manufacturer's instructions, hybridized to the array and scanned on an Illumina HiScan. Genotyping calls were made with GenomeStudio (Illumina) via the cluster files provided by the manufacturer. The GenCall (v.6.3.0) threshold was set to 0.15, and the call rates were greater than 0.998. Reproducibility and heritability were calculated in GenomeStudio (Illumina). CNVs were identified using the cnvPartition Plugin v.3.2.0 in GenomeStudio (Illumina). The cnvPartition confidence threshold was set at 100, with a minimum number of SNPs per CNV region of 10. All CNVs were visually verified by assessing both the B-allele-frequency and Log R ratios. Statistical analyses were performed using the t-test (Statview Software, SAS Institute) with statistical significance set at 0.01-0.05. CNV calls were validated using qPCR or by STR analysis. MethylC-seq library construction. One microgram of genomic DNA was spiked with 5 ng unmethylated cl857 Sam7 Lambda DNA (Promega, Madison, Wisconsin, USA). The DNA was fragmented with a Covaris S2 (Covaris, Woburn, Massachusetts, USA) to 150-200 bp, followed by end repair and addition of a 39 adenine base. Cytosinemethylated adapters provided by Illumina (Illumina, San Diego, California, USA) were ligated to the sonicated DNA at 16 uC for 16 h with T4 DNA ligase (New England Biolabs). Adaptor-ligated DNA was isolated by two rounds of purification with AMPure XP beads (Beckman Coulter Genomics, Danvers, Massachusetts, USA). Adaptor-ligated DNA (#450 ng) was subjected to sodium bisulphite conversion using the MethylCode kit (Life Technologies, Carlsbad, California, USA) as per the manufacturer's instructions. The bisulphite-converted, adaptor-ligated DNA molecules were enriched by eight cycles of PCR with the following reaction composition: 25 ml of Kapa HiFi Hotstart Uracil1 Readymix (Kapa Biosystems, Woburn, Massachusetts,USA) and 5 ml TruSeq PCR Primer Mix (Illumina) (50 ml final). The thermocycling parameters were: 95 uC 2 min, 98 uC 30 s, then four cycles of 98 uC 15 s, 60 uC 30 s and 72 uC 4 min, ending with one 72 uC 10-min step. The RESEARCH ARTICLE reaction products were purified using AMPure XP beads. Up to two separate PCR reactions were performed on subsets of the adaptor-ligated, bisulphite-converted DNA, yielding up to two independent libraries from the same biological sample. MethylC-seq mapping. Sequencing reads were first trimmed for adaptor sequence using Cutadapt 37 . All cytosines in the trimmed reads were then computationally converted to thymines and mapped twice, to a converted forward strand reference and to a converted reverse strand reference both based on the hg19 reference genome. A converted reference is created by replacing all cytosines with thymines (forward strand) or all guanines with adenines (reverse strand) in the reference FASTA file. For mapping we used Bowtie 38 with the following options: '-S', '-k 1', '-m 1', '-chunkmbs 3072', '-best', '-strata', '-o 4', '-e 80', '-l 20', and '-n 0'. Any read that mapped to multiple locations was removed and one read from each starting location on each strand from each library was kept (that is, clonal reads were removed). Methylation calling. To call methylated sites, we summed the number of reads that supported methylation at a site and the number of reads that did not. We used these counts to perform a binomial test with a probability of success equal to the nonconversion rate, which was determined by computing the fraction of methylated reads in the lambda genome (spiked in during library construction). The false discovery rate (FDR) for a given P-value cut-off was computed using Benjamini-Hochberg approach. Because the P-value distributions for each methylation context are different, this procedure was applied to each three nucleotide context independently (for example, a P-value cut-off was calculated for CAT cytosines). DMR finding. We simultaneously identified DMRs in all samples using the following two-step process 31 . The first step involved performing a root-mean-square test on each individual CG as outlined in a previous report 39 . For this test, we constructed a contingency table where the rows indicated a particular sample and the columns indicated the number of reads that supported a methylated cytosine or an unmethylated cytosine at this position in a given sample. The P values were simulated using 3,000 permutations. For each permutation, a new contingency table was generated by randomly assigning reads to cells with a probability equal to the product of the row marginal and column marginal divided by the total number of reads squared. To speed up this process, if a P value returned 100 permutations with a statistic greater than or equal to the original test statistic, we stopped running permutations (that is, we used adaptive permutation testing). To determine a P-value cut-off that would control the false discovery rate (FDR) at our desired rate (1%), we used the procedure reported before 40 . In brief, this method first generates a histogram of the P values and calculates the expected number of P values to fall in a particular bin under the null. This expected count is computed by multiplying the width of the bin by the current estimate for the number of true null hypotheses (m 0 ), which is initialized to the number of tests performed. It then looks for the first bin (starting from the most significant bin and working its way towards the least significant) where the expected number of P values is greater than or equal to the observed value. The differences between the expected and observed counts in all the bins up to this point are summed, and a new estimate of m 0 is generated by subtracting this sum from the current total number of tests. This procedure was iterated until convergence, which we defined as a change in the m 0 estimate of less than or equal to 0.01. With this m 0 estimate, we were able to estimate the FDR of a given P value by multiplying the P value by the m 0 estimate (the expected number of positives at that cut-off under the null hypothesis) and dividing that product by the total number of significant tests we detected at that P-value cut-off. We chose the largest P-value cut-off that still satisfied our FDR requirement. Once this P-value cut-off was chosen, significant sites were combined into blocks if they were within 250 bases of one another and had methylation changes in the same direction (for example, sample A was hypermethylated and sample B was hypomethylated at both sites). A sample was considered hypo-or hypermethylated if the deviation of observed counts from the expected counts was in the top or bottom 1% of deviations. These residuals were calculated using the following formula below for a given cell in row i and column j:
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where i is the row index and j is the column index of the cell for which you are calculating the residual, C is the total number of columns, R is the total number of rows, N is the total number of observations, and k and l are row index and column index variables for the two respective summation functions. The distinction between hypermethylation and hypomethylation was made based on the sign of the residuals. For example, if the residual for the methylated read count of sample A was positive, it was counted as hypermethylation. Furthermore, blocks that contained fewer than 10 differentially methylated sites were discarded.
Methylation levels. Throughout the paper we refer to the methylation levels of regions in various contexts. Unless otherwise noted, these methylation levels are more specifically weighted methylation levels as defined in the previous report 41 . Identification of CG DMRs. The DMR-finding algorithm described above was applied on hESO-7 and hESO-8, H1, H9, HUES6, NT1-4, iPS-S1 and iPS-S2, iPSR1and iPS-R2, FF-iPS 6.9, FF-iPS 19.7, FF-iPS 19.11, iMR90-iPS and ADS-iPS cell lines. In total, 5,138 DMRs were obtained. Then, assuming that each DMR splits the samples into two groups, a hypomethylated group and a hypermethylated group, we took the largest difference between neighbouring ranked values and divided the groups. Any DMR with a split less than 0.1 was discarded (861 DMRs) because its methylation pattern is obscure. The remaining 4,277 DMRs were then segregated further and only DMRs containing uniform agreement of all five IVF ES cell lines were considered (1,075 DMRs remaining): only DMRs where all ES lines were either all in the hypomethylation group or hypermethylation group were chosen. Lastly, only DMRs where the five IVF ES cell groups separated from at least one NT or one iPS cell line were included in the main figures. This yielded the final number of 678 DMRs that was used for further analyses. Memory, NT-specific and iPS-cell-specific DMRs. Memory DMRs are defined as CG DMRs that shared the same methylation state with the progenitor HDFs. NT-specific DMRs (ntDMRs) or iPS cell-specific DMRs (iDMRs) are regions where the methylation states in the sample group match neither to HDFs nor to the IVF ES cell state. Identification of non-CG mega DMRs. To identify non-CG mega DMRs, we first divided genome into 5-kb non-overlapping bins. For each bin, the non-CG methylation level (mCH/CH) was computed as weighted methylation level minus bisulphite non-conversion rate and mCH/CH was then normalized by dividing by the median mCH/CH of the 5-kb bin. Next, the Mann-Whitney test was used to compare the median normalized mCH/CH of every 10 consecutive bins (sliding window) of each sample (NTs, iPS cells from this study and iPS cells from our previous study 8 , and the average of all five IVF ES cells (H1, H9, HUES6, hESO-7 and hESO-8). Sliding windows were significantly non-CG differentially methylated if they showed more than two fold changes than the average IVF ES cell sample and had a P value below 5% FDR (Benjamini-Hochberg). Next, for each sample, significant sliding windows were merged if they were within 100 kb and showed changes in the same direction compared with the average ES cell sample (non-CG hypomethylated or hypermethylated).
To get a set of regions that aberrant non-CG methylation presented, we merged all non-CG mega DMRs from all iPS cell and NT ES cell samples if they were within 100 kb. In total, 150 merged non-CG mega DMRs were obtained. In the rest of the analyses, we used non-CG mega DMRs called in each samples. Clustering samples by methylation states of non-CG mega DMRs. Normalized mCH/CH was computed for all non-CG mega DMRs. 1 2 Pearson correlation coefficient was used as distance metric. Function 'hclust' in R with option 'ward' was used for hierarchical clustering. Permutation to estimate the significance of closeness of non-CG mega DMRs to centromeres and telomeres. Merged non-CG mega DMRs were shuffled within autosomes of human reference genome (hg19) excluding ENCODE blacklisted regions. This permutation was conducted 1,000 times to estimate the distribution of median distance of shuffled non-CG mega DMRs to centromeric and telemeric regions. The significance (P value) of closeness to centromeric and telemeric regions was defined as the fraction of permutations that median distances of shuffled non-CG mega DMRs were less than the median distance of unshuffled non-CG mega DMRs. Expression analysis on genes inside non-CG mega DMRs. The number of genes within non-CG mega DMRs in each sample was counted as the number of genes that overlapped (at least 1 bp) non-CG mega DMRs identified in each sample. To evaluate the effect of aberrant non-CG methylation on gene expression, for each sample, we computed the log 2 fold change of reads per kb per million (RPKM) of genes that overlapped non-CG mega DMRs in that sample to that in ES cells. Permutation was used to estimate the significance of change in RPKM. For hypomethylated non-CG mega DMRs, we randomly picked the same number of genes (as number of genes that overlapped non-CG mega DMRs) in each iPS cell or NT ES cell sample and counted the total number of genes that showed more than a 10% decrease in expression compared with the average expression in ESCs. The permutation was run 1,000 times and the significance (P value) was defined as the percentage of permutations in which the random set showed more than a 10% decrease in expression rather than our set of non-CG mega DMRs. For hypermthylated non-CG mega DMRs, analysis was similar except that we analysed the number of genes that showed 10% increase rather than decrease in our test statistics. DAVID 42, 43 was used to conducted gene ontology 32 analysis to find out enriched terms related to genes that overlapped merged non-CG DMRs identified in NT ES cells and iPS cells from this study. The top five significant annotation clusters were reported in Supplementary ARTICLE RESEARCH
